Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats

Neurotoxicity Research

Volumn 10, Issue 1, 2006, Pages 11-22

  Romero, Cesar A ^a   Bustamante, Diego A ^a   Zapata Torres, Gerald ^a   Goiny, Michel ^b   Cassels, Bruce ^a   Herrera Marschitz, Mario ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amphetamine; Drug abuse; Ecstasy; Microdialysis; Rat; Rotation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; BIOGENIC AMINE; OXIDOPAMINE;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BRAIN LEVEL; CHEMISTRY; COMPARATIVE STUDY; DIALYSIS; DOSE RESPONSE; DRUG EFFECT; MALE; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; RAT; STEREOTYPY; WISTAR RAT;

AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; DIALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXIDOPAMINE; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR;

EID: 33750604811     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033330     Document Type: Article

References (64)

1. Abekawa T, T Ohmori and T Koyama (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643, 276-281.
2. Axt KJ and ME Molliver (1991) Immunohistochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9, 302-313.
3. Brown JM, GR Hanson and AE Fleckenstein (2000) Methamphetamine rapidly decreases vesicular dopamine uptake. J. Neurochem. 74, 2221-2223.
4. Brunswick DJ, S Benmassour, SM Tejami-Butt and M Hauptmann (1992) Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11, 287-293.
5. Buchanan JF and CR Brown (1988) "Designer drugs" a problem in clinical toxicology. Med. Toxicol. 3, 1-17.
6. Burrows KB, WL Nixdorf and BK Yamamoto (2000) Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines. J. Pharmacol. Exp. Ther. 292, 853-860.
7. Bustamante D, Y Zhi-Bing, MN Castel, S Johansson, M Goiny, L Terenius, T Hökfelt and M Herrera-Marschitz (2002) Effect of repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J. Neurochem. 83, 645-654.
8. Bustamante D, G Díaz-Véliz, C Paeile, G Zapata-Torres and BK Cassels (2004) Analgesic and behavioral effects of amphetamine, p-methoxyamphetamine and N-alkyl-p-methoxyamphetamine derivatives. Pharmacol. Biochem. Behav. 79, 199-212.
9. Butcher SP, IS Fairbrother, JS Kelly and GW Arbuthnott (1988) Amphetamine-induced release in the rat striatum: An in vivo microdialysis study. J. Neurochem. 50, 346-355.
10. Byard RW, J Gilbert, R James and RJ Lokan (1998) Amphetamine derivate fatalities in South-Australia. Is "ecstasy" the culprit? Am. J. For. Med. Pathol. 19, 261-265.
11. de la Torre R, J Ortuño, M Mas, M Farre and J Segura (1999) Fatal MDMA intoxication. Lancet 353, 593.
12. Eisch AJ, SJ O'Dell and JF Marshall (1996) Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 22, 217-225.
13. Felgate HE, PD Felgate, RA James, DN Sims and DC Vozzo (1998) Recent paramethoxyamphetamine deaths. J. Anal. Toxicol. 22, 69-172.
14. Fibiger HC and EG McGeer (1971) Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur. J. Pharmacol. 16, 176-180.
15. Fleckenstein AE, RR Metzger, JW Gibb and GR Hanson (1997) A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur. J. Pharmacol. 323, 9-10.
16. Frey K, M Kilbourn and T Robinson (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur. J. Pharmacol. 334, 273-279.
17. Fuxe K and U Ungerstedt (1970) Histochemical biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration, In: Amphetamine and Related Compounds (Costa E, Ed.) (Raven Press:NEw York), pp 257-288.
18. Gough B, SZ Imam, B Blough, W Slikker Jr and SF Ali (2002) Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: A microdialysis study. Ann. NYAcad. Sci. 965, 410-420.
19. Green AR, AO Mechan, JM Elliott, E O'Shea and MI Colado (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55, 463-508.
20. Haughey JM, AE Fleckenstein, RR Metzger and GR Hanson (2000) The effects of methamphetamine on serotonin transporter activity: Role of dopamine and hyperthermia. J. Neurochem. 75, 1608-1617.
21. Herrera-Marschitz M and U Ungerstedt (1984a) Evidence striatal efferents relate to different dopamine receptors. Brain Res. 323, 269-278.
22. 2 receptor sites. Eur. J. Pharmacol. 98, 165-176.
23. Herrera-Marschitz M, H Utsumi and U Ungerstedt (1990) Scoliosis in rats with experimentally-induced hemiparkinsonism: Dependence upon striatal dopamine denervation. J. Neurol. Neurosurg. Psychiatr. 53, 39-43.
24. Herrera-Marschitz M, JJ Meana, WT O'Connor, M Goiny, MS Reid and U Ungerstedt (1992) Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gammaaminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis, reciprocal interactions. Amino Acids 2, 157-179.
25. Herrera-Marschitz M, Z-B You, M Goiny, JJ Meana, R Silveira, O Godukhin, Y Chen, S Espinoza, E Pettersson, F Loidl, G Lubec, K Andersson, I Nylander, L Terenius and U Ungerstedt (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia by in vivo microdialysis. J. Neurochem. 66, 1726-1735.
26. Holson RR, JF Bowger, P Clausing and B Bough (1996) Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion. Brain Res. 739, 301-307.
27. Hotchkiss AJ and JW Gibb (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257-260.
28. Johansen SS, AC Hansen, IB Muller, JB Lundemose and MB Franzmann (2003) Three fatal cases of PMA and PMMA poisoning in Denmark. J. Anal Toxicol. 27, 253-256.
29. Johnson M, AA Letter, K Merchant, GR Hanson and JW Gibb (1988) Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. J. Pharmacol. Exp. Ther. 244, 977-982.
30. Kalant H (2001) The pharmacology and toxicology of ecstasy (MDMA) and related drugs. Can. Med. J. Assn. 165, 917-928.
31. Kleven MS and LS Seiden (1992) Methamphetamine-induced neurotoxicity: structure activity relationships. Ann. NY Acad. Sci. 654, 292-301.
32. Kraner JC, DJ McCoy, MA Evans, LE Evans and BJ Sweeney (2001) Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA). J. Anal. Toxicol. 25, 645-648.
33. Kuczenski R and DS Segal (1992) Differential effects of methamphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085-1094.
34. Kuczenski R, D Segal, AK Cho and W Melega (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioural responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15, 1308-1317.
35. Lebsanft HB, A Mayerhofer, KA Kovar and WJ Schmidt (2003) Is the esctasy-induced ipsilateral rotation in 6-OHDA unilaterally lesioned rats dopamine independent? J. Neural Transm. 110, 707-718.
36. Marek GJ, G Vosmer and LS Seiden (1990) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 513, 274-279.
37. Marshall JF, SJ O'Dell and FB Weihmuller (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J. Neural Transm. 91, 241-254.
38. Martin TL (2001) Three cases of fatal paramethoxyamphetamine overdose. J. Anal. Toxicol. 25, 649-651.
39. Nash JF and BK Yamamoto (1992) Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581, 237-243.
40. Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. J. Psychoactive Drugs 18, 305-313.
41. Nixdorf WL, KB Burrows, GA Gudelsky and BK Yamamoto (2001) Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by energy inhibitor malonate. J. Neurochem. 77, 647-654.
42. O'Dell SJ, FB Weihmuller and JF Marshall (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564, 256-260.
43. Paxinos G and C Watson (1982) The Rat Brain in Stereotaxic Coordinates (Academic Press:SAn Diego, CA).
44. Peat MA, PF Warren, C Bakhit and JW Gibb (1985) The acute effects of methamphetamine and p-chloro-amphetamine on the cortical serotonergic system of the rat brain: Evidence for differences in the effects of methamphetamine and amphetamine. Eur. J. Pharmacol. 116, 11-16.
45. Pentney AR (2001) An exploration of the history and controversies surrounding MDMA and MDA. J. Psychoactive Drugs 33, 213-221.
46. Pu C and CV Vorhees (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocytes reaction in rat striatum. Dev. Brain Res. 72, 325-328.
47. Pu C, EJ Fisher, GP Cappon and CV Vorhees (1994) The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopamine terminal degeneration and astrocytic response in rat striatum. Brain Res. 649, 217-224.
48. Randrup AS and I Munkvad (1966) Role of catecholamines in the amphetamine excitatory response. Nature 211, 540.
49. Ricaurte GA, CR Schuster and LS Seiden (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res. 193, 153-163.
50. Sabol KE, JT Roach, SL Broom, C Ferreira and MM Preau (2001) Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res. 892, 122-129.
51. Schmidt CJ (1987) Acute administration of methylenedioxyamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogues. Eur. J. Pharmacol. 136, 81-88.
52. Schmidt CJ and JW Gibb (1985) Role of the dopamine uptake carrier in the neurotoxic response to methamphetamine: Effect of amfonelic acid. Eur. J. Pharmacol. 109, 73-80.
53. Seiden LS, CR Fischman and CR Schuster (1976) Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Dependend. 1, 215-219.
54. Sonsalla PK, WJ Nicklas and RE Heikkila (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243, 398-400.
55. Steele TD, JC Katz and GA Ricaurte (1992) Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA). Brain Res. 589, 349-352.
56. Stephans SE and BK Yamamoto (1994) Methamphetamineinduced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17, 203-209.
57. Stone DM, DC Stahl, GR Hanson and JW Gibb (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4- methylenedioxyamphetamine (MDA) on monoaminergic systems in the brain. Eur. J. Pharmacol. 128, 41-48.
58. Stone DM, M Johnsson, GR Hanson and JW Gibb (1987) A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 134, 245-248.
59. Tseng L-F, MK Menon and HH Loh (1976) Comparative actions of the monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue. J. Pharmacol. Exper. Ther. 197, 263-271.
60. Ungerstedt U (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotationalbehaviour. Acta Physiol. Scand. 367, 49-68.
61. Ungerstedt U and GW Arbuthnott (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
62. Ungerstedt U, M Herrera-Marschitz, U Jungnelius, L Ståhle, U Tossman and T Zetterström (1982) Dopamine synaptic mechanisms reflected in studies combining behavioural recordings and brain dialysis. Adv. Biosci. 37, 219-231.
63. Zetterström T, T Sharp, CA Marsden and U Ungerstedt (1983) In vivo measurement of dopamine and its metabolites studied by intracerebral dialysis: Changes after D-amphetamine. J. Neurochem. 41, 1769-1773.
64. Zetterström T, M Herrera-Marschitz and U Ungerstedt (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376, 1-7.